antipyrine has been researched along with prednisolone in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (39.39) | 18.7374 |
| 1990's | 1 (3.03) | 18.2507 |
| 2000's | 11 (33.33) | 29.6817 |
| 2010's | 8 (24.24) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, MH; Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Akamatsu, M | 1 |
| Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Dancis, J; Jansen, V; Levitz, M | 1 |
| Addison, RS; Cannell, GR; Harvey, TJ; Maguire, DJ; Mortimer, RH | 1 |
| Christensen, HR; Døssing, M; Evald, T; Loft, S; Simonsen, K; Sonne, J | 1 |
| Hieber, F | 1 |
| Furkert, K | 1 |
| Fujimura, H; Ito, M; Suzuki, Y; Yamagami, I | 1 |
| Mayr, E | 1 |
| Ballinger, B; Browning, M; O'Malley, K; Stevenson, IH | 1 |
| Dinnendahl, V; Kalbhen, DA | 1 |
| Pelkonen, RO; Puukka, M; Sotaniemi, EA | 1 |
| Garg, SK; Mathur, VS; Shukla, VK | 1 |
| HIEMEYER, V | 1 |
| BUECH, O; JAHN, U; WAGNER-JAUREGG, T | 1 |
| MIRECKI, GB | 1 |
2 review(s) available for antipyrine and prednisolone
| Article | Year |
|---|---|
[Otologic agents. 13].
Topics: Adrenal Cortex Hormones; Aminopyrine; Anesthetics, Local; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Inflammatory Agents; Antipyrine; Benzocaine; Chloramphenicol; Disinfectants; Ear Diseases; Formaldehyde; Humans; Hydrocortisone; Lidocaine; Neomycin; Nitrofurazone; Prednisolone; Procaine; Tetracaine; Toluene | 1967 |
[Antirheumatic drugs. 40].
Topics: Aminopyrine; Analgesics; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antimalarials; Antipyrine; Camphor; Chloroquine; Dexamethasone; Esters; Flufenamic Acid; Glucocorticoids; Gold; Humans; Immunosuppressive Agents; Indomethacin; Mefenamic Acid; Methylprednisolone; Nicotinic Acids; Oils, Volatile; Oxyphenbutazone; Prednisolone; Prednisone; Rheumatic Diseases; Salicylates; Triamcinolone | 1969 |
31 other study(ies) available for antipyrine and prednisolone
| Article | Year |
|---|---|
ElogPoct: a tool for lipophilicity determination in drug discovery.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Solvents | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The transfer and metabolism of corticosteroids in the perfused human placenta.
Topics: Antipyrine; Betamethasone; Dexamethasone; Female; Humans; Hydrocortisone; In Vitro Techniques; Placenta; Prednisolone; Pregnancy | 1978 |
A comparison of parameters used to standardize results from in vitro perfusions of human placentae.
Topics: Antipyrine; Biological Transport, Active; Creatinine; Female; gamma-Glutamyltransferase; Glucose; Humans; In Vitro Techniques; Inulin; Oxygen Consumption; Perfusion; Placenta; Prednisolone; Pregnancy | 1992 |
Influence of prednisolone on antipyrine elimination in patients with obstructive lung disease.
Topics: Antipyrine; Female; Humans; Liver; Lung Diseases, Obstructive; Male; Metabolic Clearance Rate; Middle Aged; Prednisolone | 1987 |
[Report on the critical testing of the combination preparation Ultra-Demoplas in orthopedic practice].
Topics: Amines; Antipyrine; Arthritis; Dexamethasone; Drug Combinations; Escin; Evaluation Studies as Topic; Female; Humans; Injections, Intramuscular; Male; Phenylbutazone; Plants, Medicinal; Prednisolone; Pyridoxine; Rheumatic Diseases; Thiamine; Vitamin B 12; Vitamin B 6 | 1972 |
[Influence of various drugs on tissue permeability].
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Antipyrine; Ascorbic Acid; Bromelains; Coloring Agents; Cysteine; Female; Furosemide; Histamine; Hydrogen-Ion Concentration; Injections, Intradermal; Injections, Subcutaneous; Methods; Papain; Pentobarbital; Pepsin A; Permeability; Pharmacology; Phenylbutazone; Prednisolone; Rats; Rutin; Salicylates; Skin; Skin Absorption; Time Factors | 1969 |
Drug-metabolizing capacity in states of drug dependence and withdrawal.
Topics: Adult; Aged; Antipyrine; Barbiturates; Drug Tolerance; Female; Half-Life; Humans; Male; Methaqualone; Middle Aged; Prednisolone; Substance Withdrawal Syndrome; Substance-Related Disorders | 1972 |
[Pharmacology studies on the influencing of chondroitin sulfate decomposition in vitro].
Topics: Aminopyrine; Anti-Inflammatory Agents; Antipyrine; Aspirin; Chemical Phenomena; Chemistry; Chloroquine; Chondroitin; Copper; Densitometry; Flavonoids; Flufenamic Acid; Glucosamine; Hyaluronoglucosaminidase; Iron; Lidocaine; Male; Malonates; Methylamines; Oxyphenbutazone; Prednisolone; Rutin; Sodium Chloride; Sodium Salicylate; Sulfates; Testis; Triazines | 1971 |
Measurement of hepatic drug-metabolizing enxyme activity in man. Comparison of three different assays.
Topics: Adult; Aged; Antipyrine; Cytochrome P-450 Enzyme System; Enzyme Induction; Female; Glucaric Acid; Hepatitis; Histamine H1 Antagonists; Humans; Liver; Liver Cirrhosis; Male; Medroxyprogesterone; Middle Aged; Pharmaceutical Preparations; Phenobarbital; Phenytoin; Prednisolone; Rifampin | 1980 |
Influence of prednisolone on antipyrine and chloramphenicol disposition in rabbits.
Topics: Animals; Antipyrine; Chloramphenicol; Half-Life; Kinetics; Male; Prednisolone; Rabbits | 1984 |
[Comparative studies on the antiphlogistic effect of nicotinoamide-phenyl-dimethylpyrazolone and its combination with prednisone].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Humans; Inflammation; Niacin; Niacinamide; Prednisolone; Prednisone | 1963 |
[The antiphlogistic testing of known antirheumatics on kaolin-induced rat paw edema].
Topics: Aminopyrine; Analgesics; Analgesics, Non-Narcotic; Animals; Antipyretics; Antipyrine; Azoles; Edema; Inflammation; Kaolin; Magnesium; Phenacetin; Phenylbutazone; Prednisolone; Rats; Salicylamides | 1962 |
[FURTHER EXPERIENCES WITH VERTEBRAN IN ORTHOPEDIC PRACTICE].
Topics: Analgesics; Analgesics, Non-Narcotic; Antipyretics; Antipyrine; Atropine; Back Pain; Brachial Plexus Neuritis; Caffeine; Drug Therapy; Ergotamine; Humans; Hydrocortisone; Joint Diseases; Osteochondritis; Polymyalgia Rheumatica; Prednisolone; Prednisone; Procaine; Reflex Sympathetic Dystrophy; Spinal Osteophytosis; Spondylitis; Spondylitis, Ankylosing; Strychnine | 1965 |